Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study ; volume:10 ; number:2 ; day:25 ; month:2 ; year:2023 ; pages:291-298 ; date:6.2023
Drugs - real world outcomes ; 10, Heft 2 (25.2.2023), 291-298, 6.2023
- Urheber
-
Robinson, Suganthy
Moon, Tang Min
Eng, Tey Kwee
Yuen, Teoh Tze
Jong, Tang Jyh
Selvarajah, Latha
Chiang, Tan Wooi
Chiat, Teh Yeon
Tiong, John
Chinthapatla, Harini
Eng, Shu Kee
Thevarajah, Suganthi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-023-00359-1
- URN
-
urn:nbn:de:101:1-2023091208531172824403
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Robinson, Suganthy
- Moon, Tang Min
- Eng, Tey Kwee
- Yuen, Teoh Tze
- Jong, Tang Jyh
- Selvarajah, Latha
- Chiang, Tan Wooi
- Chiat, Teh Yeon
- Tiong, John
- Chinthapatla, Harini
- Eng, Shu Kee
- Thevarajah, Suganthi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Biologic system evaluation with ultrasound
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis
Treatment of Atopic Dermatitis with Biologic Drugs
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Biologic system evaluation with ultrasound
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis
Treatment of Atopic Dermatitis with Biologic Drugs
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Biologic system evaluation with ultrasound
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis
Treatment of Atopic Dermatitis with Biologic Drugs
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis